[Reduction of serum triglycerides with a combined application of butylbiguanide and clofibrate in animal experiments].
When given separately, neither butylbiguanide (N1-butylbiguanide-hydrochloride, the active principle of Silubin retard) (75 mg/kg) nor clofibrate (30 mg/kg) decreased the serum triglycerides in normolipaemic rats. In combined administration, however, the two drugs produced a statistically significant average decrease in serum triglycerides by 30%. Simultaneous administration of the two drugs also lowered triglycerides in rats with carbohydrate-induced hypertriglyceridaemia.